ArticleFrontiers in endocrinology2025
A successful remote patient monitoring program for diabetes.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Implementing a RPM-enabled transitional care pathway for adults with poorly controlled diabetes: a quality improvement initiative.BMJ open quality · 2026Article
- Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook.Current diabetes reports · 2026Review
- Integrating Pharmacists into CGM-Enabled Digital Diabetes Care: Advancing Personalized and Data-Driven Management.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of diabetes continues to rise in the United States along with a shortage of endocrinologists. One proposed solution to this challenge is to deliver more specialty health care services through remote patient monitoring (RPM). Here, we describe our initial experience with an RPM program for diabetes care at the University of Colorado. We enrolled 211 patients with primarily uncontrolled type 2 diabetes into the Diabetes Home and Remote Care Program (DHRCP). Remote care replaced traditional brick-and-mortar care while patients were enrolled. A certified diabetes care and education specialists (CDCES) contacted patients every 1-2 weeks to provide lifestyle coaching and assess medication compliance. With oversight from an endocrinologist, frequent medication adjustments were made by the CDCES. Analysis performed on 106 (50.2%) patients who met graduation criteria and had a hemoglobin A1c (HbA1c) completed upon program graduation showed an average decrease in HbA1c from 10.4% to 7.0% (p<0.001). Overall, our results demonstrate that RPM is an effective care model for improving glycemic control in patients with diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.